Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Embla

Explore full profile

Embla provides an online science-backed weight loss treatment using prescription medication, digital coaching and gamification

Copenhagen, DenmarkFounded 2021Health Tech & Medtech
Valuation $50–100M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Embla and the history behind them.

About Embla

Embla is an innovative startup that provides a comprehensive online weight loss solution. The company combines medications, health coaching, and digital tools to help individuals achieve and maintain significant weight loss. Embla's approach is holistic, meaning it looks at the whole person, not just their diet. This is reflected in their motto: "Our diet is not a diet." Instead of focusing solely on food intake, Embla integrates modern medicine and personalised coaching to support long-term weight management.

Embla serves a diverse range of clients who are looking for effective and sustainable weight loss solutions. These clients typically include individuals struggling with obesity or those who have tried traditional diets without success. The company operates in the health and wellness market, which is a rapidly growing sector as more people seek healthier lifestyles and effective weight management solutions.

The business model of Embla is subscription-based. Clients pay a monthly fee for unlimited access to video and chat consultations with doctors, nurses, and health coaches. This continuous support ensures that clients receive personalized advice and adjustments to their weight loss plans as needed. The company makes money through these subscription fees, which provide a steady stream of revenue.

Embla's Chief Medical Officer, Henrik Gudbergsen, is a qualified doctor and PhD from Copenhagen University. His research focuses on how medications and dietary changes can be used to maintain weight loss, which underpins the company's evidence-based approach.

In summary, Embla offers a unique, all-encompassing weight loss solution that leverages modern medicine, personalized coaching, and digital tools to help clients achieve their weight loss goals.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Copenhagen, Denmark
Employees
53
Open positions
3
Dealroom signal
79.7/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Pharmacy, Weight Management, Telemedicine, Nutrition, Metabolism, Hard Tech, Digital Care
Technology
Mobile app
Business model
SaaS
Client focus
b2c

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Aug 2023 $11M $44M Inovo.vc · VentureFriends · Crowberry Capital · Founders (Denmark) ↗
SEED✓Equity / VC Aug 2022 $3.9M $15M VentureFriends · Crowberry Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearProfitMargin
2026 —
2025 —
2024 —
2023 —
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Embla website traffic

Latest recorded traffic for Embla is 31K monthly website visits, up 40.9% over the last three months. Embla's team grew 12.8% over the past year.

Latest monthly visits31K 3-month web change+40.9% 1-year team growth+12.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • VentureFriends
  • Crowberry Capital

Series A3 investors entered at this stage

Other known investors1 additional known investor

  • Simon Sylvest
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇩🇰 Denmark51.2%
🇺🇸 United States21.9%
🇬🇧 United Kingdom12.2%
🇨🇭 Switzerland4.9%
🇸🇪 Sweden2.4%
Top 5 of 8 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Embla on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Embla’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.